Results 101 to 110 of about 3,778 (172)
Obesity, Volume 33, Issue 4, Page 659-670, April 2025.Abstract Objective The aim of this study was to investigate the effects of zoledronic acid for the prevention of bone loss after bariatric surgery. Methods In this randomized, double‐blinded study, 59 patients undergoing Roux‐en‐Y gastric bypass or sleeve gastrectomy (mean [SD], age: 48.9 [6.3] years, BMI: 42.3 [5.3], 73% female) were randomly assigned
Søren Gam +6 more
wiley +1 more source
Otolaryngology–Head and Neck Surgery, Volume 172, Issue 4, Page 1199-1207, April 2025.Abstract Objective The objective of this study is to examine the risk of hypocalcemia after thyroidectomy in patients taking histamine‐2 receptor antagonists. Study Design Retrospective cohort study. Setting Multicenter, single database. Methods Thirty‐four thousand two hundred eighteen patients treated with total thyroidectomy from 2011 to 2022 were ...
Maxwell Rossip +6 more
wiley +1 more source
World Journal of Surgery, Volume 49, Issue 4, Page 1011-1021, April 2025.Abstract Background American Thyroid Association guidelines support active surveillance (AS) for low‐risk papillary thyroid cancer (PTC). We developed a calculator to aid patient selection. Methods From 2004 to 2020, 148,904 PTC patients were selected from the surveillance, epidemiology, and end results (SEER) database.
Stanton Nielsen +8 more
wiley +1 more source
World Journal of Surgery, Volume 49, Issue 4, Page 985-996, April 2025.Does a restrictive diagnostic work‐up for thyroid nodules lead to a different papillary thyroid cancer patient population? A comparison between Dutch and U.S. PT1–T3 patient population. Abstract Introduction The 2015 American Thyroid Association guidelines recommend de‐escalating surgical treatment for papillary thyroid cancer (PTC).
Maaike B. C. ten Hoor +9 more
wiley +1 more source
The history of thyroidectomy [PDF]
Journal of the Royal Society of Medicine, 1998 openaire +3 more sources
British Journal of Clinical Pharmacology, Volume 91, Issue 4, Page 1233-1240, April 2025.Aims A 42‐year‐old male developed chronic primary hypoparathyroidism after total thyroidectomy. Conventional therapy led to recurrent nephrolithiasis and therefore rhPTH(1‐84) (parathyroid hormone [PTH]) treatment was considered. According to the dosing guideline for PTH, calcium plasma levels are adequately controlled with once‐daily administration ...
Maira Visscher +5 more
wiley +1 more source
Clinical Endocrinology, Volume 102, Issue 4, Page 482-489, April 2025.ABSTRACT Objective To estimate the incidence, prevalence, patient characteristics and healthcare utilization patterns of moderate to severe thyroid eye disease (TED) in the United States. Design Retrospective review of medical and prescription claims data from the Inovalon deidentified claims database. Patients Patients with moderate to severe TED were
Marius N. Stan +8 more
wiley +1 more source
How Does Thyroid Hormone Profile Differ on and Off Replacement Treatment?
Clinical Endocrinology, Volume 102, Issue 4, Page 490-495, April 2025.ABSTRACT Introduction There continues to be much discussion around optimisation of thyroid hormone status in hypothyroid individuals. We here looked the way that free T4(FT4) and thyroid‐stimulating hormone (TSH) related to each other in a large laboratory sample of people who underwent a thyroid function test (TFT), split between those on ...
Adrian H. Heald +8 more
wiley +1 more source
The Adverse Impact of Tyrosine Kinase Inhibitors on Wound Healing and Repair
International Wound Journal, Volume 22, Issue 4, April 2025.ABSTRACT Tyrosine kinase inhibitors (TKIs) can treat various cancers, primarily through their antiangiogenic effects. However, as angiogenesis is crucial for successful wound healing, TKIs may adversely impact wound repair. This review analysed all 63 FDA‐approved TKIs and identified evidence for wound healing and repair implications in 24 agents.
William J. Nahm, Vincent Falanga
wiley +1 more source